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E-mail: cmi.leffad@gmail.comIntroductionNew Microbes and New Infections (NMNI) remains a young
journal having been launched during the ESCMID Congress in
Berlin, April 2013, partly as a companion and referral journal
to Clinical Microbiology and Infection (CMI), edited by Didier
Raoult and from 2016 by Leonard Leibovici [1,2]. NMNI aims
to provide a platform for international authors reporting
facts in infectious and primarily tropical diseases and clinical
microbiology that are new in one particular place and
country. Accordingly, NMNI acknowledges contributions
from emerging research teams offering the opportunity to
publish in their own language, in addition to English; two such
papers, dually accepted in French and English, have been
published in 2015 [3] and 2016 [4]. In the meantime, NMNI
has been included in PubMed Central, obviously increasing its
visibility and the interest of authors and readers. We hope
this is just a ﬁrst step towards referencing in PubMed and
inclusion in the impact factor rankings within the next few
years.Editorial structureNMNI is an online-only journal, meaning that authors can
submit their contributions any time and that accepted papers
are released any time, by chronological order of acceptance.
NMNI is reviewing papers in English, French, German, Spanish,
Portuguese, Russian, Arabic and Chinese thanks to a panel of
international Editors who are greatly thanked for their kind
contributions to the editorial process. Accepted papers will beNew Microbes and New Infections © 2016 The Authors. Published by El
This is an open access artipublished in the original language version and in English after the
corresponding author has approved the English translation.
Papers can be submitted in any of 12 categories with the un-
derstanding that papers must report reliable facts in infectious
and tropical diseases and clinical microbiology that are new in
one particular geographic region. A new category named
“Taxonogenomics” has been launched in 2015, to accommo-
date reports of new bacterial, viral, fungal and parasite species,
along with genomes of thereof.Editorial activityIn 2015, NMNI received 110 submissions including 28 (26 %)
submissions referred from CMI. Of the 110 submitted papers,
86 % were accepted for publication including two papers from
Tunisian authors dually accepted in French and in English. Of
accepted papers, 5 were sponsored by ESCMID where all fees
were covered by ESCMID. Altogether, a total of 186 papers
were accepted for publication since the launch of NMNI and
156 are now indexed in PubMed Central with a regular pro-
gression in the number of submitted papers. The graph pre-
sents the geographical origin of accepted papers, indicating that
NMNI is on its way to achieving its main goal, the rapid pro-
motion of discoveries in infectious and tropical diseases and
clinical microbiology made by emerging research teams (Fig. 1).NMNI reportsThe current citation rate is 0.615 (2015 citations received
divided by 2015 articles and reviews) and our next objective
will be to submit an application to Thomson Reuters for
indexing in the Web of Science. Accordingly the most cited
article has 12 citations, the 2nd most cited has 9 citations
and the 3rd most cited articles have 8 citations [5–7]. In
addition, a total of 40,309 full-text article downloads wereNew Microbe and New Infect 2016; -: 1–2
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FIG. 1. Geographical origin of papers accepted for publication in NMNI, 2015.
2 New Microbes and New Infections, Volume - Number -, --- 2016 NMNIreceived across all Journal platforms by the end December,
2015.PerspectivesBy strengthening its Editorial Board, NMNI will decrease the
time to online publication which is still longer than the goal of 2
months obviously, the continuing efforts of the Editorial Board
will also enhance the chances of early acceptance for PubMed
indexing and of the inclusion in Thomson Reuters’ impact factor
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